Karyopharm Shareholders Approve Major Authorized Share Increase
at www.tipranks.com (Thu, 19-Feb 4:43 PM)
Piper Sandler Reaffirms Their Buy Rating on Karyopharm Therapeutics (KPTI)
at www.tipranks.com (Thu, 19-Feb 7:17 AM)
Karyopharm Eyes Transformational 2026 Milestones as Revenue Climbs and Phase 3 Readouts Approach
Market Chameleon (Wed, 18-Feb 8:27 AM)
Upcoming Clinical Catalysts and Cost Controls Drive Interest in Karyopharm’s (KPTI) 2025 Results
Market Chameleon (Thu, 12-Feb 11:07 AM)
Karyopharm Targets Clinical Milestones Despite Wider Losses: SENTRY and EC-042 Pave Way for 2026
Market Chameleon (Thu, 12-Feb 9:14 AM)
